Floatz logo

MITOMYCIN C

Metastatic Malignant Neoplasm in the Peritoneum

City of Hope Medical CenterSmall moleculePhase 3Active
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

36 Active assets in the Metastatic Malignant Neoplasm in the Peritoneum cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Peking University
Phase 2BB
Docetaxel
University of Pittsburgh
Phase 2BB
FLUOROURACILUM
City of Hope Medical Center
Phase 3BB
Mirvetuximab Soravtansine
AbbVie
Phase 3BB
Rucaparib
pharmaand GmbH
Phase 3BB

View all 50 →

Same molecule, other indications

MITOMYCIN C is also rated in:

colorectal carcinomaDormant
BB
Indicative ·
67 / 100
View asset →
appendix carcinomaDormant
BB
Indicative ·
67 / 100
View asset →
peritoneal carcinomatosisDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →